Epidiolex May Have Avoided CRL Over Metabolite Assessment Due To Unmet Need

Lead pharmacology/toxicology reviewer said Epdiolex was not approvable because of inadequate assessment of 7-COOH-CBD human metabolite, but supervisor said it could be conducted in postmarketing phase because of the unmet need the drug fills.